Publications

The Oral Nicotine 2020 Report is an online, free-content publication to raise awareness and explain the role of oral nicotine delivery systems in tobacco harm reduction. For cigarette smokers who cannot or will not quit, switching to tobacco-free oral nicotine will help prevent tobacco-related disease and premature death.

New research by the University of Nairobi shows Kenyans are using a variety of oral stimulants and each carries its own varying degree of risk. The study shows users are more likely to consume the riskier products such as chewing tobacco, areca and khat. It leads us to a simple conclusion: we should be making much greater effort to encourage these people towards available tobacco-free products that carry a lesser risk, such as nicotine replacement therapies (NRT) and nicotine pouches.

Oral diseases affect 3.5 billion people globally, significantly impacting quality of life and creating substantial economic burdens. Smoking, with 1.27 billion users worldwide, remains the most preventable cause of death and a major contributor to oral diseases and cancer.